150 related articles for article (PubMed ID: 38502494)
21. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
22. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.
Dillon M; Flander L; Buchanan DD; Macrae FA; Emery JD; Winship IM; Boussioutas A; Giles GG; Hopper JL; Jenkins MA; Ait Ouakrim D
PLoS Med; 2018 Aug; 15(8):e1002630. PubMed ID: 30114221
[TBL] [Abstract][Full Text] [Related]
23. Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods.
Borkhoff CM; Saskin R; Rabeneck L; Baxter NN; Liu Y; Tinmouth J; Paszat LF
Can J Public Health; 2013 Jun; 104(4):e284-90. PubMed ID: 24044467
[TBL] [Abstract][Full Text] [Related]
24. Area-level income disparities in colorectal screening in Canada: evidence to inform future surveillance.
Blair A; Gauvin L; Ouédraogo S; Datta GD
Curr Oncol; 2019 Apr; 26(2):e128-e137. PubMed ID: 31043818
[TBL] [Abstract][Full Text] [Related]
25. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
26. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
Patel VB; Nahar R; Murray B; Salner AL
Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
[TBL] [Abstract][Full Text] [Related]
27. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
[TBL] [Abstract][Full Text] [Related]
28. Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada.
Vahabi M; Lofters A; Wong JP; Ellison L; Graves E; Damba C; Glazier RH
Cancer Med; 2019 Nov; 8(16):7108-7122. PubMed ID: 31568705
[TBL] [Abstract][Full Text] [Related]
29. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys.
Kelly DM; Estaquio C; Léon C; Arwidson P; Nabi H
BMJ Open; 2017 Dec; 7(12):e016941. PubMed ID: 29247085
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer screening for average-risk North Americans: an economic evaluation.
Heitman SJ; Hilsden RJ; Au F; Dowden S; Manns BJ
PLoS Med; 2010 Nov; 7(11):e1000370. PubMed ID: 21124887
[TBL] [Abstract][Full Text] [Related]
31. Social inequalities in a population based colorectal cancer screening programme in the Basque Country.
Hurtado JL; Bacigalupe A; Calvo M; Esnaola S; Mendizabal N; Portillo I; Idigoras I; Millán E; Arana-Arri E
BMC Public Health; 2015 Oct; 15():1021. PubMed ID: 26438240
[TBL] [Abstract][Full Text] [Related]
32. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
[TBL] [Abstract][Full Text] [Related]
33. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
[TBL] [Abstract][Full Text] [Related]
34. A Novel Approach to Analyze Disparities in Colorectal Cancer Screening and Mortality.
Honaker MD; Burch AE; Wong JH; Akram WM; Irish WD
J Surg Res; 2024 Jun; 298():347-354. PubMed ID: 38663261
[TBL] [Abstract][Full Text] [Related]
35. Cancer screening inequities in a time of primary care reform: a population-based longitudinal study in Ontario, Canada.
Lofters AK; Mark A; Taljaard M; Green ME; Glazier RH; Dahrouge S
BMC Fam Pract; 2018 Aug; 19(1):147. PubMed ID: 30157772
[TBL] [Abstract][Full Text] [Related]
36. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
[TBL] [Abstract][Full Text] [Related]
37. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.
Ladabaum U; Mannalithara A; Meester RGS; Gupta S; Schoen RE
Gastroenterology; 2019 Jul; 157(1):137-148. PubMed ID: 30930021
[TBL] [Abstract][Full Text] [Related]
38. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
39. Trends in Sociodemographic Disparities in Colorectal Cancer Staging and Survival: A SEER-Medicare Analysis.
Liang PS; Mayer JD; Wakefield J; Trinh-Shevrin C; Kwon SC; Sherman SE; Ko CW
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00155. PubMed ID: 32352722
[TBL] [Abstract][Full Text] [Related]
40. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
